Hetemäki I. i in. (2021), An outbreak caused by the SARS-CoV-2 Delta variant (B. 1.617. 2) in a secondarycarehospital in Finland, May 2021, „Eurosurveillance” 26.30 (2021): 2100636.
Ioannidis J.P.A. (2021), Benefit of COVID-19 vaccination accounting for potential risk compensation, „npj Vaccines” 6, 99, https://doi.org/10.1038/s41541-021-00362-z, dostęp: 28 grudnia 2021.
Kampf G. (2021), COVID-19: stigmatising the unvaccinatedis not justified, „The Lancet” 398.10314: 1871.
Kampf G. (2021a), The epidemiologicalrelevance of the COVID-19-vaccinated populationisincreasing, „The Lancet RegionalHealth – Europe” 11
Kroidl I. i in. (2021), Vaccine breakthrough infection and onward transmission of SARS-CoV-2 Beta (B. 1.351) variant, Bavaria, Germany, February to March 2021, „Eurosurveillance” 26.30: 2100673.
NguyenVanVinhChaui in. (2021), An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam, „EClinicalMedicine”41:101143, https://www.sciencedirect.com/science/article/pii/S2589537021004235, dostęp: 28 grudnia 2021.
Nordström P., Ballin M., Nordström A. (2021), Effectiveness of Covid-19 vaccination against risk of symptomatic infection, hospitalization, and death up to 9 months: a Swedish total-population cohort study, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3949410, dostęp: 28 grudnia 2021.
Pollett S.D. i in. (2021), The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity, “Clinical Infectious Diseases” ciab543, https://doi.org/10.1093/cid/ciab543, dostęp: 4 stycznia 2022
Riemersma K.K. i in. (2021), Shedding of infectious SARS-CoV-2 despite vaccination, medRXiv, https://www.medrxiv.org/content/10.1101/2021.07.31.21261387v6, dostęp: 4 stycznia 2022.
Singanayagam A. i in. (2021), Communitytransmission and viralloadkinetics of the SARS-CoV-2 delta (B. 1.617. 2) variant in vaccinated and unvaccinatedindividuals in the UK: a prospective, longitudinal, cohortstudy, „The Lancet InfectiousDiseases”, https://doi.org/10.1016/S1473-3099(21)00648-4, dostęp: 4 stycznia 2022.
Zheng C. i in. (2021), Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis, „International Journal of Infectious Diseases” 114: 252-260.
